US nutrition startup Berry Street merges with India's Healthify as GLP-1 trends upwards
US nutrition startup Berry Street has merged with India-based Healthify to capture growing demand for GLP-1 weight-loss drugs. The combined entity will run as co-CEOs and operate under different brand names in the US and India.
Intelligence analysis by Llama
Berry Street and Healthify are merging to build a transatlantic metabolic-care platform targeting the GLP-1 boom, with co-CEOs Noah Kotlove and Tushar Vashisht at the helm. Neither company disclosed deal terms, but together they claim 45 million-plus customers and 2,000 clinics.
Two food-and-health app companies, one from America and one from India, decided to join forces because lots of people are starting to use new weight-loss medicines called GLP-1s. Together they can help way more people, with doctors in America and a smart coaching app everywhere else.
Analysis
45 million customers at the starting line
Healthify, the Khosla Ventures-backed Indian platform, claims it has served more than 45 million customers through its AI and human nutrition-coaching app, while Berry Street says it has reached over 200,000 users through partnerships with Amazon, Walmart, and other distribution channels. The order-of-magnitude gap between those two numbers captures the strategic logic of the merger: Healthify brings consumer scale and an AI coaching engine that has been refined for a decade, while Berry Street adds the United States clinical and insurance plumbing that Healthify needs if it is going to charge real money for metabolic care in America. Pooling a 45-million-user funnel with 2,000 clinics and insurer relationships is a structurally different business than either company on its own.
30 million Americans on GLP-1s by 2030
The announcement leans on a JP Morgan research note projecting that more than 30 million people in the U.S. will be on GLP-1 drugs by 2030, a number that explains the urgency of the deal. Berry Street was already positioned to capture a slice of that demand with insurance-covered GLP-1 care and meal-tracking software, but its 200,000-person reach looks small next to the addressable market. Healthify began offering GLP-1-aided programs in India last year and expanded into the US in 2024, so the merger folds an established pharmacy-and-clinic operation together with a coaching product that has spent ten years iterating on adherence and behavior change. If the JP Morgan number is roughly right, the combined entity inherits a tailwind that neither founder could have built around alone.
Tushar Vashisht and Noah Kotlove as co-CEOs
Both founders keep their titles. Noah Kotlove, who founded Berry Street, and Tushar Vashisht, who founded Healthify, will run the new entity as co-CEOs, with the US operating under the Berry Street name and international markets continuing under the Healthify brand. The structure is meant to preserve the cultural and regulatory fit of each regional team rather than impose a single identity, and it sidesteps a common failure mode in cross-border health mergers where one side is effectively acquired. Vinod Khosla, whose firm backs Healthify, framed the combination as the platform that will "redefine metabolic care," and Vashisht cast Berry Street's clinic network as the "clinical backbone" Healthify needs to deliver at US scale. Neither side disclosed financial terms, so the equity split and any cash component of the deal remain undisclosed, leaving open how much of the $200 million-plus the two startups have raised between them is being concentrated or diluted.
Key points
- US-based Berry Street and India's Healthify have merged, with founders Noah Kotlove and Tushar Vashisht serving as co-CEOs
- The companies did not disclose the financial terms of the deal
- Healthify is backed by Khosla Ventures and has raised more than $150 million, per Crunchbase; Berry Street raised $50 million from Northzone, Sofina, and FJ Labs
- Berry Street operates a network of more than 2,000 clinics and offers insurance-covered GLP-1 care in the US
- A JP Morgan report cited by the companies projects more than 30 million Americans will be on GLP-1 drugs by 2030
- Healthify claims to have served more than 45 million customers; Berry Street says it has served over 200,000 people through partners including Amazon and Walmart
If the JP Morgan projection of 30 million US GLP-1 users by 2030 holds, the combined clinic network and insurance contracts could make the merged entity the default front door for medically supervised weight management in America, while Healthify's app distributes that playbook to its claimed 45 million users abroad. Pairing AI coaching with insurance-billable clinical visits is a reimbursement structure that most consumer nutrition apps have never been able to assemble.
Mergers between consumer health apps and clinic operators have a poor track record when the two cultures, regulatory regimes, and unit economics collide, and this one spans two countries, two reimbursement systems, and two founder-led teams still sharing the C-suite. Deal terms were not disclosed, so the equity split, board control, and any earn-out mechanics remain unclear, which often presages post-close friction.
